selected scholarly activity
-
academic article
- Sialidase down-regulation reduces non-HDL cholesterol, inhibits leukocyte transmigration, and attenuates atherosclerosis in ApoE knockout mice. Journal of Biological Chemistry. 293:14689-14706. 2018
- Suppression of NK and CD8 + T cells reduces astrogliosis but accelerates cerebellar dysfunction and shortens life span in a mouse model of Sandhoff disease. Journal of Neuroimmunology. 306:55-67. 2017
- Asialoglycoprotein receptors as important mediators of plasma lipids and atherosclerosis. Current Opinion in Lipidology. 28:209-212. 2017
- Neuronal pentraxin 1 depletion delays neurodegeneration and extends life in Sandhoff disease mice. Human Molecular Genetics. 26:ddw422-ddw422. 2017
- Bi-phasic gliosis drives neuropathology in a Sandhoff disease mouse model. Journal of Neuroimmunology. 299:19-27. 2016
- Characterization of Proliferating Lesion‐Resident Cells During All Stages of Atherosclerotic Growth. Journal of the American Heart Association. 5. 2016
- The Effects of Diet on Occlusive Coronary Artery Atherosclerosis and Myocardial Infarction in Scavenger Receptor Class B, Type 1/Low-Density Lipoprotein Receptor Double Knockout Mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 34:2394-2403. 2014
- The effect of pomegranate extract on coronary artery atherosclerosis in SR-BI/APOE double knockout mice. Atherosclerosis. 228:80-89. 2013
- SR-BI in Bone Marrow Derived Cells Protects Mice from Diet Induced Coronary Artery Atherosclerosis and Myocardial Infarction. PLoS ONE. 8:e72492-e72492. 2013
- Transient neonatal hyperparathyroidism: a presenting feature of sialidosis type II. Journal of Pediatric Endocrinology and Metabolism. 26:767-769. 2013
- Hypomorphic sialidase expression decreases serum cholesterol by downregulation of VLDL production in mice. Journal of Lipid Research. 53:2573-2585. 2012
- Miglustat as a therapeutic agent: prospects and caveats. Journal of Medical Genetics. 49:591-597. 2012
- The therapeutic potential of pharmacological chaperones and proteosomal inhibitors, Celastrol and MG132 in the treatment of sialidosis. Molecular Genetics and Metabolism. 107:173-185. 2012
- A point mutation in the neu1 promoter recruits an ectopic repressor, Nkx3.2 and results in a mouse model of sialidase deficiency. Molecular Genetics and Metabolism. 97:43-52. 2009
- Regulation of SR-BI-mediated selective lipid uptake in Chinese hamster ovary-derived cells by protein kinase signaling pathways. Journal of Lipid Research. 48:405-416. 2007
- The inhibition of endocytosis affects HDL-lipid uptake mediated by the human scavenger receptor class B type I. Molecular Membrane Biology. 24:442-454. 2007
- Functional rescue of vitamin C synthesis deficiency in human cells using adenoviral-based expression of murine l-gulono-γ-lactone oxidase. Genomics. 83:482-492. 2004
- Late onset Tay–Sachs disease in mice with targeted disruption of the Hexa gene: behavioral changes and pathology of the central nervous system. Brain Research Brain Research Protocols Molecular Brain Research. 1001:37-50. 2004
- Five novel mutations in the lysosomal sialidase gene (NEU1) in type II sialidosis patients and assessment of their impact on enzyme activity and intracellular targeting using adenovirus-mediated expression. Human Mutation. 23:32-39. 2004
- Cathepsin A Is Expressed in a Cell- and Region-specific Manner in the Testis and Epididymis and Is Not Regulated by Testicular or Pituitary Factors. Journal of Histochemistry and Cytochemistry. 48:1131-1146. 2000
- Role of sphingolipids in the transport of prosaposin to the lysosomes.. Journal of Lipid Research. 40:1593-1603. 1999
- Sialidase-mediated depletion of GM2 ganglioside in Tay-Sachs neuroglia cells. Human Molecular Genetics. 8:1111-1116. 1999
- Cloning of the cDNA and Gene Encoding Mouse Lysosomal Sialidase and Correction of Sialidase Deficiency in Human Sialidosis and Mouse SM/J Fibroblasts. Human Molecular Genetics. 7:115-120. 1998
- Apoptotic Cell Death in Mouse Models of GM2 Gangliosidosis and Observations on Human Tay-Sachs and Sandhoff Diseases. Human Molecular Genetics. 6:1879-1885. 1997
- Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis. Nature Genetics. 15:316-320. 1997
- The Saccharomyces cerevisiae processing alpha 1,2-mannosidase is localized in the endoplasmic reticulum, independently of known retrieval motifs.. European Journal of Cell Biology Cytobiologie. 70:298-305. 1996
- Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases. Trends in Genetics. 12:170-170. 1996
- Dramatically Different Phenotypes in Mouse Models of Human Tay-Sachs and Sandhoff Diseases. Human Molecular Genetics. 5:1-14. 1996
- Molecular role of sulfated glycoprotein-1 (SGP-1/prosaposin) in Sertoli cells.. Histology and Histopathology. 10:1023-1034. 1995
- Ultrastructural and immunocytochemical study of skin fibroblasts from normal and sialidosis patients. Cell and Tissue Research. 278:527-534. 1994
- Purification and Partial Characterization of an Autotomy-Promoting Factor from the Sea StarPycnopodia helianthoides. Biological Bulletin. 176:169-175. 1989
-
conference paper
- SR-BI in Bone Marrow Derived Cells Protects Mice From Diet Induced Coronary Artery Atherosclerosis and Myocardial Infarction. Canadian Journal of Cardiology. S268-S268. 2013
- TRANSIENT NEONATAL HYPERPARATHYROIDISM: A PRESENTING FEATURE OF SIALIDOSIS TYPE II. Journal of Inherited Metabolic Disease. S101-S101. 2012
- Transcriptional induction of human lysosomal sialidase promoter as a potential strategy for the treatment of Tay Sachs disease. Molecular Genetics and Metabolism. S22-S22. 2011
- 67. Immune cell phenotypes and cytokine response in a mouse model of sialidase deficiency. Molecular Genetics and Metabolism. S22-S22. 2010
- 68. Impact of tumor necrosis factor-alpha deletion on astrolgliosis and microgliosis in the CNS of Sandhoff mice. Molecular Genetics and Metabolism. S22-S22. 2010
- PO22-699 PREVENTION OF ATHEROSCLEROSIS IN APOE KNOCKOUT MICE USING SIALIDASE INHIBITORS: A NEW CLASS OF ANTI-ATHEROGENIC DRUGS. Atherosclerosis Supplements. 187-187. 2007
- Th-W60:6 Tissue-specific sialidase deficiency protects against atherosclerosis in experimental animals. Atherosclerosis Supplements. 488-488. 2006
- Long-term correction of sialidase deficiency in cells and mice by recombinant helper-dependent adenovirus-mediated gene transfer.. Genetics in Medicine. 248-248. 2004
- Molecular mechanisms of TNF alpha mediated hepatic leukocyte recruitment. FASEB Journal. A623-A623. 2004
- Differential roles of lysosomal and proteasomal degradation in the life-cycle of Cx43 in gap junctional intercellular communication-deficient and -competent breast tumor cells. Molecular Biology of the Cell Cell Regulation. 353A-353A. 2002
- Point mutations in the lysosomal sialidase gene cause tissue-specific sialidase deficiency in SM/J mice. Molecular Biology of the Cell Cell Regulation. 104A-104A. 2002
- HIGH EXPRESSION OF ALPHA-MANNOSIDASE IB IN PLACENTA AND INT HE NERVOUS-SYSTEM. Molecular Biology of the Cell Cell Regulation. 489-489. 1995
- SITE-SPECIFIC ANTIBODY RECOGNIZES THE LYSOSOMAL BUT NOT THE SECRETED FORM OF PROSAPOSIN SULFATED GLYCOPROTEIN-1 OF RAT SERTOLI CELLS. Molecular Biology of the Cell Cell Regulation. A12-A12. 1992